Regenerative and personalized medicine is based on the body's innate reparative, immunomodulatory and regenerative capabilities. There is an enormous, definitive and growing body of peer-reviewed scientific literature dedicated to these areas. Obtaining predictable outcomes for specific indications and patient cohorts requires, first and foremost, an understanding of that science. It also requires, however, the design of processes for its efficient application in the context of a busy clinical practice. Our Clinical/Scientific Advisory Board and global network comprise recognized leaders in cell science, and the practical clinical translation of that science.
From basic endotoxin screens to flow cytometry, we procure devices and design models for clinically accessible characterization methods.
Real World Evidence
inCytes™ allows clinicians to design, capture, report and share unique clinical evidence.
We assemble external, multi-disciplinary advisory committees to establish strong foundations for scientific excellence, medical ethics and international growth.
We connect our partners with the thriving Regenerative Medicine device industry to help support pre and post-market studies and trials.